FK-PC101

· Cellvax Therapeutics Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FK-PC101, covering 2024-10-21 to 2024-10-21. Get the full timeline:

Most recent: Clinical Trial Update: FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer [Phase 2]